The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned.
Clin Chest Med
; 44(2): 335-346, 2023 06.
Article
in English
| MEDLINE | ID: covidwho-2275611
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Extracorporeal Membrane Oxygenation
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Clin Chest Med
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS